IL-8 dictates glycosaminoglycan binding and stability of IL-18 in cystic fibrosis.
AuthorsReeves, Emer P
Bergin, David A
Smith, Stephen G J
O'Neill, Shane J
McElvaney, Noel G
AffiliationRespiratory Research Division, Department of Medicine, Royal College of Surgeons in Ireland, Education and Research Centre, Beaumont Hospital, Dublin, Ireland. firstname.lastname@example.org
Bronchoalveolar Lavage Fluid
Cell Line, Transformed
MetadataShow full item record
CitationIL-8 dictates glycosaminoglycan binding and stability of IL-18 in cystic fibrosis. 2010, 184 (3):1642-52 J. Immunol.
JournalJournal of immunology (Baltimore, Md. : 1950)
AbstractDysregulation of airway inflammation contributes to lung disease in cystic fibrosis (CF). Inflammation is mediated by inflammatory cytokines, including IL-8, which illustrates an increase in biological half-life and proinflammatory activity when bound to glycosaminoglycans (GAGs). The aim of this project was to compare IL-8 and IL-18 for their relative stability, activity, and interaction with GAGs, including chondroitin sulfate, hyaluronic acid, and heparan sulfate, present in high quantities in the lungs of patients with CF. Bronchoalveolar lavage fluid was collected from patients with CF (n = 28), non-CF controls (n = 14), and patients with chronic obstructive pulmonary disease (n = 12). Increased levels of IL-8 and reduced concentrations of IL-18 were detected in bronchial samples obtained from CF individuals. The low level of IL-18 was not a defect in IL-18 production, as the pro- and mature forms of the molecule were expressed and produced by CF epithelial cells and monocytes. There was, however, a marked competition between IL-8 and IL-18 for binding to GAGs. A pronounced loss of IL-18 binding capacity occurred in the presence of IL-8, which displaced IL-18 from these anionic-matrices, rendering the cytokine susceptible to proteolytic degradation by neutrophil elastase. As a biological consequence of IL-18 degradation, reduced levels of IL-2 were secreted by Jurkat T lymphocytes. In conclusion, a novel mechanism has been identified highlighting the potential of IL-8 to determine the fate of other inflammatory molecules, such as IL-18, within the inflammatory milieu of the CF lung.
- Nebulized hypertonic saline decreases IL-8 in sputum of patients with cystic fibrosis.
- Authors: Reeves EP, Williamson M, O'Neill SJ, Greally P, McElvaney NG
- Issue date: 2011 Jun 1
- [Early bronchial inflammation in cystic fibrosis].
- Authors: Puchelle E
- Issue date: 2002
- Quantitative cytokine gene expression in CF airway.
- Authors: Muhlebach MS, Reed W, Noah TL
- Issue date: 2004 May
- The effect of the decoy molecule PA401 on CXCL8 levels in bronchoalveolar lavage fluid of patients with cystic fibrosis.
- Authors: McElvaney OJ, O'Reilly N, White M, Lacey N, Pohl K, Gerlza T, Bergin DA, Kerr H, McCarthy C, O'Brien ME, Adage T, Kungl AJ, Reeves EP, McElvaney NG
- Issue date: 2015 Feb
- Lower airway inflammation in infants with cystic fibrosis detected by newborn screening.
- Authors: Armstrong DS, Hook SM, Jamsen KM, Nixon GM, Carzino R, Carlin JB, Robertson CF, Grimwood K
- Issue date: 2005 Dec